Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier

Overview of attention for article published in Molecular Neurodegeneration, January 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)

Mentioned by

news: 1 news outlet

twitter: 13 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 24 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 14 X posts from 13 X users, with an upper bound of 22,774 followers.

RT @USC_ZilkhaNeuro: A #ZNI study used anti-malaria drug artesunate to treat AD model mice. The drug upregulates #PICALM, a genetic risk fa…

24 Jun 2023

Reply Repost Favourite

RT @USC_ZilkhaNeuro: A #ZNI study used anti-malaria drug artesunate to treat AD model mice. The drug upregulates #PICALM, a genetic risk fa…

23 Jun 2023

Reply Repost Favourite

A #ZNI study used anti-malaria drug artesunate to treat AD model mice. The drug upregulates #PICALM, a genetic risk factor for AD. Mice that received the drug had improved pathology, cognitive function, and vascular function. #alzheimersawarenessmonth ht

23 Jun 2023

Reply Repost Favourite

RT @bbbpapers: Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain b…

30 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 10 additional X posts.